Skip to main content
. 2022 Jan 18;66(1):e01879-21. doi: 10.1128/AAC.01879-21

TABLE 6.

Correlational analysis of biofilm phage susceptibility and oxacillin, linezolid, rifampin, daptomycin, clindamycin, and levofloxacin susceptibilitya

Antibiotic No. of antibiotic- susceptible isolates No. of antibiotic intermediate isolates No. of antibiotic- resistant isolates Phage P value
Oxacillin 18 NA 7 ATCC 11988-B1 0.3047
48 NA 26 ATCC 19685-B1 0.6044
42 NA 15 ATCC 23360-B1 0.8444
Clindamycin 16 NA 9 ATCC 11988-B1 0.2620
52 NA 21 ATCC 19685-B1 0.9879
40 NA 17 ATCC 23360-B1 0.1331
Rifampin 25 NA 0 ATCC 11988-B1 NA
72 NA 2 ATCC 19685-B1 0.2638
56 NA 1 ATCC 23360-B1 0.5243
Daptomycin 11 NA 0 ATCC 11988-B1 NA
35 NA 0 ATCC 19685-B1 NA
24 NA 0 ATCC 23360-B1 NA
Levofloxacin 10 8 7 ATCC 11988-B1 0.5772b
29 22 23 ATCC 19685-B1 0.4102b
23 18 16 ATCC 23360-B1 0.7386b
Linezolid 12 NA 0 ATCC 11988-B1 NA
24 NA 0 ATCC 19685-B1 NA
25 NA 0 ATCC 23360-B1 NA
a

The Wilcoxon rank sum test with normal approximation was performed to assess correlation between oxacillin, linezolid, rifampin, daptomycin, clindamycin, or levofloxacin susceptibility and biofilm phage response as measured by percent reduction under treated versus control conditions in biological replicates, α = 0.05. NA, not applicable.

b

Kruskal-Wallis test with chi square approximation was performed to accommodate nonbinary levofloxacin susceptibility data.